{
    "symbol": "ONCY",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-07 11:03:05",
    "content": "  As a reminder, various remarks made during this call contain certain forward-looking statements relating to the Company's business prospects and the development and commercialization of pelareorep, including statements regarding the Company's focus, strategy and objectives, Company's belief as to the potential and mode of action of pelareorep as a cancer therapeutic, design, aims and anticipated benefits of the current -- company's current and in clinical trials and anticipated timing of the release of the additional data, Company's plans and expectations regarding potential registrational study, Company's business development plans and strategies and other statements related to anticipated developments in the company's business."
}